Price
Target price
€65.50
€65.50
-0.760%
-0.5
-0.760%
€107.78
24.04.24 / Frankfurt
WKN: A0DN17 / Symbol: PBH / Name: Prestige Consumer Healthcare / Stock / Food & Drug Retailing / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Prestige Consumer Healthcare Inc. Stock
The price for the Prestige Consumer Healthcare Inc. stock decreased slightly today. Compared to yesterday there is a change of -€0.500 (-0.760%).
Currently there is a rather positive sentiment for Prestige Consumer Healthcare Inc. with 4 Buy predictions and 0 Sell predictions.
With a target price of 107 € there is a hugely positive potential of 63.36% for Prestige Consumer Healthcare Inc. compared to the current price of 65.5 €.
Pros and Cons of Prestige Consumer Healthcare Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
S********** s********
Cons
?
B****
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Prestige Consumer Healthcare Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Prestige Consumer Healthcare Inc. | -0.760% | 3.937% | -2.941% | 17.857% | 18.919% | 74.603% | 164.211% |
| Apollo Medical Holdings, Inc. | -1.710% | -0.568% | -4.372% | 2.339% | -2.235% | - | - |
| Petmed Express Inc | -0.470% | -2.400% | -10.988% | -72.221% | -43.176% | -85.314% | - |
| Ingles Markets Inc | -2.170% | 0.730% | -1.429% | -18.824% | -10.390% | 33.981% | - |
Comments
Prestige Consumer Healthcare Inc. (NYSE: PBH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for PBH provided by MarketBeat
Prestige Consumer Healthcare Inc. (NYSE: PBH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for PBH provided by MarketBeat
Prestige Consumer Healthcare Inc. (NYSE: PBH) had its price target lowered by analysts at BMO Capital Markets from $124.00 to $117.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for PBH provided by MarketBeat